Verbal memory after three months of intranasal vasopressin in healthy old humans

Psychoneuroendocrinology

Volumn 22, Issue 6, 1997, Pages 387-396

  Perras, Boris ^a   Droste, Claudia ^a   Born, Jan ^a,b   Fehm, Horst L ^a   Pietrowsky, Reinhard ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

Author keywords

Elderly; Human; Intranasal; Memory; Subchronic; Vasopressin

Indexed keywords

VASOPRESSIN;

AGE; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; LEARNING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERBAL MEMORY;

ADMINISTRATION, INTRANASAL; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; VASOPRESSINS; VERBAL LEARNING;

EID: 0030749287     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(97)00047-4     Document Type: Article

References (45)

1. Alliot, J. and Alexinsky, T. (1991) Food-restriction interacts with vasopressin modulation of activity. Physiology and Behavior 50, 213-220.
2. Anderson, J. R. and Pirolli, P. L. (1984) Spread of activation. Journal of Experimental Psychology: Learning, Memory and Cognition 10, 791-798.
3. Balin, B. J., Broadwell, R. D., Salcman, M. and El-Kalliny, M. (1986) Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat and squirrel monkey. Journal of Comparative Neurology 251, 260-280.
4. Beckwith, B. E., Petros, T. V., Bergloff, P. J. and Staebler, R. J. (1987) Vasopressin analogue (DDAVP) facilitates recall of narrative prose. Behavioral Neuroscience 101, 429-432.
5. Bleecker, M. L., Bolla-Wilson, K., Agnew, J. and Meyers, D. A. (1988) Age related sex differences in verbal memory. Journal of Clinical Psychology 44, 403-411.
6. Crawford, J. R., Stewart, L. E. and Moore, J. W. (1989) Demonstration of savings on the AVLT and development of a parallel form. Journal of Clinical and Experimental Neuropsychology 11, 975-981.
7. De Kloet, E. R. and Reul, J. M. H. M. (1987) Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogenity of brain receptor systems. Psychoneuroendocrinology 12, 83-105.
8. De Wied, D. (1965) The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats. International Journal of Neuropharmacology 4, 157-167.
9. Fehm-Wolfsdorf, G., Voigt, K. H. and Fehm, H. L. (1983) Human memory and lysin-vasopressin: a psychological study. In Neuropeptides and Psychosomatic Processes: eds. E. Endröczi. L. Angelucci, D. De Wied, U. Scapagnini, pp. 81-88. Akademiai Kiado, Budapest.
10. Fehm-Wolfsdorf, G. and Born, J. (1991) Behavioral effects of neuro-hypophyseal peptides in healthy volunteers: 10 years of research. Peptides 12, 1399-1406.
11. Fliers, E., Swaab, D. F., Pool, C. W. and Verwer, R. W. H. (1985) The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus: changes with aging and in senile dementia. Brain Research 342, 45-53.
12. Heubrock, D. (1992) Der Auditiv-Verbale Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse. Zeitschrift für differentielle und diagnostische Psychologie 3, 161-174.
13. Hofman, M. A. and Swaab, D. F. (1994) Alterations in circadian rhythmicity of the vasopressin producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Research 651, 134-142.
14. Ivnik, R. J., Petersen, R. C., Malec, J. F., Kokmen, E., Tangalos, E. G. and Kurland, L. T. (1990) The Auditory-Verbal Learning Test (AVLT): norms for Ages 55 and older. Psychological Assessment 3, 304-312.
15. Jennings, J. R., Nebes, R. D. and Reynolds, C. F.III (1986) Vasopressin peptide (DDAVP) may narrow the focus of attention in normal elderly. Psychiatry Research 17, 31-39.
16. Jolles, J. (1983) Vasopressin-like peptides and the treatment of memory disorders in man. Progress in Brain Research 60, 169-182.
17. Kleinsmith, L. J. and Kaplan, S. (1963) Paired-associate learning as a function of arousal and interpolated interval. Journal of Experimental Psychology 65, 190-193.
18. Laczi, F., Van Ree, J. M., Wagner, A., Valkusz, Z., Jardanhazy, T., Kovacs, G. L., Telegdy, G., Zsilard, J., Laszlo, F. A. and De Wied, D. (1983) Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and nondiabetic subjects. Acta Endocrinologica 102, 205-212.
19. Le Moal, M., Dantzer, R., Mormede, P., Baduel, A., Lebrun, C., Ettenberg, A., van der Kooy, D., Wenger, J., Deyo, S., Koob, G. F. and Bloom, F. E. (1984) Behavioural effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis. Psychoneuroendocrinology 9, 491-493.
20. Lezak, M. D. (1983) Neuropsychological Assessment. OUP, New York.
21. Loup, F., Tribollet, E., Dubois-Dauphin, M. and Dreifuss, J. J. (1991) Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Research 555, 220-232.
22. Lucassen, P. J., Salehi, A., Pod, C. W., Gonatas, N. K. and Swaab, D. F. (1994) Activation of vasopressin neurons in aging and Alzheimer's disease. Journal of Neuroendocrinology 6, 673-679.
23. Mazurek, M. F., Growdon, J. H., Beal, M. F. and Martin, J. B. (1986) Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Annals of Neurology 20, 665-670.
24. Mungas, D. (1983) Differential clinical sensitivity of specific parameters of the Rey Auditory-Verbal Lerning Test. Journal of Consulting and Clinical Psychology 51, 848-855.
25. Nebes, R. D., Reynolds, C. F. and Horn, L. C. (1984) The effect of vasopressin on memory in the healthy elderly. Psychiatry Research 11, 49-59.
26. Peabody, C. A., Thiemann, S., Pigache, R., Miller, T. P., Berger, P. A., Yesavage, J. and Tinklenberg, J. R. (1985) Desglycinamide-9-arginine-8-vasopressin (DGAVP, Org 5667) in patients with dementia. Neurobiology of Aging 6, 95-100.
27. Perras, B., Mölle, M., Born, J. and Fehm, H. L. (1996) Sleep and signs of attention during 3 months of intranasal vasopressin: a pilot study in two elderly subjects. Peptides 17, 1253-1255.
28. Pietrowsky, R., Fehm-Wolfdorf, G., Born, J. and Fehm, H. L. (1988) Effects of DGAVP on verbal memory. Peptides 9, 1361-1366.
29. Pietrowsky, R., Strüben, C., Mölle, M., Fehm, H. L. and Born, J. (1996) Brain potential changes after intranasal vs intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biological Psychiatry 39, 332-340.
30. Rey, A. (1964). L'examen clinique en psychologie. Presses Universitaires de France, Paris.
31. Riekkinen, P., Legros, J. J., Sennef, C., Jolkonnen, J., Smitz, S. and Soininen, H. (1987) Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects. Peptides 8, 261-265.
32. Sahgal, A. (1983) Vasopressin retards the acquisition of positively reinforced lever pressing in homozygous Brattleboro rats. Regulatory Peptides 5, 317-326.
33. Sahgal, A. (1984) A critique of the vasopressin-memory hypothesis. Psychopharmacology 83, 215-228.
34. Sahgal, A. (1985) Does vasopressin affect cerebral function? In The Posterior Pituitary, eds. P. H. Bayliss and P. L. Padfield, pp. 325-359. Dekker, New York.
35. Squire, L. R. (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychological Reviews 90, 195-231.
36. Sternberg, R. J. and Tulving, E. (1977) The measurement of subjective organization in free recall. Psychological Bulletin 84, 539-556.
37. Swaab, D. F. (1995) Aging of the human hypothalamus. Hormone Research 43, 8-11.
38. Till, R. E. and Beckwith, B. E. (1985) Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment. Peptides 6, 397-402.
39. Van der Woude, P. F., Goudsmit, E., Wierda, M., Purba, J. S., Hofman, M. A., Bogte, H. and Swaab, D. F. (1995) No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease. Neurobiology of Aging 16, 11-18.
40. Van Haaren, F., Van de Poll, N. E. and Van Oyen, H. G. (1985) Age effect of passive avoidance behaviour of vasopressin deficient Brattleboros. Physiology and Behavior 34, 115-117.
41. Van Wimersma Greidanus, T. B., Burbach, J. P. and Veldhuis, H. D. (1986) Vasopresssin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory. Acta Endocrinologica 276, 85-94.
42. Van Wimersma Greidanus, T. B., and Van Ree, J. M. (1990) Behavioral effects of vasopressin. In Behavioral Aspects of Neuroendocrinology, eds. G. Ganten and D. Pfaff, pp. 61-79. Springer, Berlin.
43. Weindl, A. and Sofroniew, M., (1985) Neuroanatomical pathways related to vasopressin. In Neurobiology of Vasopressin, eds. D. Ganten and D. Pfaff, pp. 137-196. Springer, Berlin.
44. Weingartner, H., Kaye, W., Gold, P., Smallberg, S., Peterson, R., Gillin, J. C. and Ebert, E. (1981) Vasopressin treatment of cognitive dysfunction in progressive dementia. Life Science 29, 2721-2726.
45. Wolters, E. C., Riekkinen, P., Lowenthal, A., Van der Plaats, J. J., Zwart, J. M. and Sennef, C. (1990) DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial. Neurology 40, 1099-1101.